Evidence map›Paper›PMID 32668192›Full record

ArticleAmerican journal of respiratory cell and molecular biology2020

TGF-β Promotes Metabolic Reprogramming in Lung Fibroblasts via mTORC1-dependent ATF4 Activation.

Erin M O'Leary, Yufeng Tian, Recep Nigdelioglu, Leah J Witt, Rengul Cetin-Atalay, Angelo Y Meliton, Parker S Woods, Lucas M Kimmig, Kaitlyn A Sun, Gizem A Gökalp and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 90 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Hallmarks of the ageing lung: 10 years later.The European respiratory journal · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. The Bi-steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in Lymphangioleiomyomatosis.American journal of respiratory cell and molecular biology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Erin M O'LearySection of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois.
Yufeng TianSection of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois.
Recep NigdeliogluDepartment of Pathology, Loyola University Medical Center, Maywood, Illinois; and.
Leah J WittDivision of Geriatrics and Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, The University of California San Francisco, San Francisco, California.
Rengul Cetin-AtalaySection of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois.
Angelo Y MelitonSection of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois.
Parker S WoodsSection of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois.
Lucas M KimmigSection of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois.
Kaitlyn A SunSection of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois.
Gizem A GökalpSection of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois.
Gökhan M MutluSection of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois.ORCID 0000-0002-2056-612X
Robert B HamanakaSection of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois.ORCID 0000-0002-8909-356X
University of Chicago · USLoyola University Medical Center · USUniversity of California, San Francisco · US

Funding

RESEARCH TRAINING IN RESPIRATORY BIOLOGYT32HL007605 · NHLBI · UNIVERSITY OF CHICAGO · PI Yun Fang, Gokhan M. Mutlu · 1985 to 2026
$18.1M
Mechanisms Underlying Sympathetic Activation-dependent Endothelial Cell Activation by Chronic Intermittent HypoxiaP01HL144454 · NHLBI · UNIVERSITY OF CHICAGO · PI PRABHAKAR, NANDURI R · 2019 to 2023
$12.7M
Particulate matter-induced changes in DNA methylome and transcriptomeU01ES026718 · NIEHS · UNIVERSITY OF CHICAGO · PI MUTLU, GOKHAN M. · 2016 to 2019
$2.5M
Metabolic Regulation of Myofibroblast DifferentiationR01HL151680 · NHLBI · UNIVERSITY OF CHICAGO · PI HAMANAKA, ROBERT BRIAN · 2020 to 2024
$2.0M
NHLBI NIH HHS P01 HL144454NHLBI NIH HHS R01 HL151680NHLBI NIH HHS T32 HL007605NIEHS NIH HHS U01 ES026718
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis is a fatal interstitial lung disease characterized by the TGF-β (transforming growth factor-β)-dependent differentiation of lung fibroblasts into myofibroblasts, which leads to excessive deposition of collagen proteins and progressive scarring. We have previously shown that synthesis of collagen by myofibroblasts requires

Indexed as

Activating Transcription Factor 4CollagenFibroblastsGlycineGlycolysisHumansLungMechanistic Target of Rapamycin Complex 1MitochondriaOxygen ConsumptionPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSerineSignal TransductionStress, PhysiologicalTOR Serine-Threonine KinasesActivating Transcription Factor 4CollagenGlycineMechanistic Target of Rapamycin Complex 1Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSerineTOR Serine-Threonine KinasesTransforming Growth Factor betafibrosisglycolysismetabolismmitochondria

Identifiers

PMID32668192
PMCPMC7605163
OpenAlexW3043103202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.